4.8 Article

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains

Chun-wa Chung et al.

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Article Biotechnology & Applied Microbiology

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Marcus Bantscheff et al.

NATURE BIOTECHNOLOGY (2011)

Review Biochemistry & Molecular Biology

Cancer epigenetics reaches mainstream oncology

Manuel Rodriguez-Paredes et al.

NATURE MEDICINE (2011)

Article Biochemistry & Molecular Biology

Multiple Interactions Recruit MLL1 and MLL1 Fusion Proteins to the HOXA9 Locus in Leukemogenesis

Thomas A. Milne et al.

MOLECULAR CELL (2010)

Article Multidisciplinary Sciences

Suppression of inflammation by a synthetic histone mimic

Edwige Nicodeme et al.

NATURE (2010)

Article Multidisciplinary Sciences

Selective inhibition of BET bromodomains

Panagis Filippakopoulos et al.

NATURE (2010)

Article Multidisciplinary Sciences

JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin

Mark A. Dawson et al.

NATURE (2009)

Article Hematology

Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation

Blaine W. Robinson et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Review Oncology

MLL translocations, histone modifications and leukaemia stem-cell development

Andrei V. Krivtsov et al.

NATURE REVIEWS CANCER (2007)

Article Biochemistry & Molecular Biology

Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease

J Wang et al.

EMBO JOURNAL (2005)

Article Biochemistry & Molecular Biology

A mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase

T Maruyama et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)